Literature DB >> 4041958

Availability of dantrolene in Canadian hospitals.

R Paasuke, A K Brownell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4041958     DOI： 10.1007/bf03010812

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  4 in total

1.  Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.

Authors:  G Ruhland; A J Hinkle
Journal:  Anesthesiology       Date:  1984-02       Impact factor: 7.892

2.  Availability of dantrolene in Canadian hospitals.

Authors:  P G Duncan
Journal:  Can Anaesth Soc J       Date:  1985-05

3.  Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia.

Authors:  E H Flewellen; T E Nelson
Journal:  Anesthesiology       Date:  1984-10       Impact factor: 7.892

4.  Malignant hyperthermia following preoperative oral administration of dantrolene.

Authors:  D C Fitzgibbons
Journal:  Anesthesiology       Date:  1981-01       Impact factor: 7.892
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.